• Innovations in Healthcare: Stryker's FDA Approval, OneMedNet's Funding, and CHMP's Nod to RYBREVANT
    1 Aug 2024
    Recent Advances in Medical Technologies and Therapies: Stryker's innovative spine surgery technology receives FDA approval, OneMedNet raises $4.6 million in private funding, and the CHMP endorses RYBREVANT® (amivantamab) combined with chemotherapy for advanced EGFR-mutated NSCLC post-therapy failure.
    Daha fazlasını göster Daha Az Göster
    5 dk.
  • Innovative Horizons: Johnson And Johnson's Medical Advances and EMVision's Portable Brain Scanner Revolution
    25 Jul 2024
    Recent Developments in Medical Technology: Johnson and Johnson Dedicate Efforts to Medical Innovation, While Australian Medtech EMVision Introduces a Portable Brain Scanner for First Responders, and Advances in Personalized Computer System-Based Therapy Improve Post-Stroke Rehabilitation.
    Daha fazlasını göster Daha Az Göster
    5 dk.
  • MedTech Momentum: Johnson & Johnson's Q2 Outlook, Bedal's $11m Leap, and CMR Surgical's New Chairman
    19 Jul 2024
    Recent headlines in the medical technology sector include Johnson & Johnson potentially leveraging MedTech to boost its Q2 performance, Bedal raising $11 million to enhance the growth of its FlexGRIP catheter device, and CMR Surgical appointing Daniel Moore as the new Non-Executive Chairman.
    Daha fazlasını göster Daha Az Göster
    5 dk.
  • MedTech Innovations Surge: Johnson & Johnson's Q2, Bedal's $11m Boost, and CMR Surgical's Leadership Change
    18 Jul 2024
    MedTech Highlights: Johnson & Johnson potentially boosts Q2 with MedTech, Bedal raises $11 million to expand FlexGRIP catheter device, and CMR Surgical names Daniel Moore as Non-Executive Chairman.
    Daha fazlasını göster Daha Az Göster
    6 dk.
  • Medikabazaar Leadership Shake-Up and Breakthrough Trends in MedTech 2024
    11 Jul 2024
    Medtech Industry Updates: Medikabazaar Rejigs Leadership, 2024 Trends Identified

    Medikabazaar has reshuffled its top management following findings from a PwC audit, while recent reports by Clarivate and a 2024 cybersecurity survey highlight emerging breakthrough trends and security concerns in the medtech sector.
    Daha fazlasını göster Daha Az Göster
    6 dk.
  • Breakthroughs and Leadership in MedTech: Insights on Clarivate, Jin Medical, Sanara, and Advanced MedTech Trends
    4 Jul 2024
    In 2024, Clarivate highlights six significant MedTech trends poised to create new industry opportunities. Additionally, an analysis compares Jin Medical International and Sanara MedTech's performance, while Advanced MedTech reports record revenues for the fiscal year alongside announcing a leadership change.
    Daha fazlasını göster Daha Az Göster
    8 dk.
  • AI MedTech Innovations: Insights from Sanara MedTech and IQVIA's Latest Achievements
    27 Jun 2024
    Recent developments in the healthcare and technology sectors show promising progress. Sanara MedTech's stock has seen a rise of 3.6% on NASDAQ. Meanwhile, PEAK:AIO is dedicating efforts towards advancing AI in healthcare. Additionally, IQVIA's SmartSolve® eQMS has been recognized with the 2024 MedTech Breakthrough Award for the Best Use of Artificial Intelligence in Healthcare, highlighting innovations in the industry.
    Daha fazlasını göster Daha Az Göster
    6 dk.
  • Navigating Innovations and Acquisitions: Salesforce, Boston Scientific, and PROCEPT BioRobotics at the Truist Securities MedTech Conference
    20 Jun 2024
    Recent updates in the medical technology sector include PROCEPT BioRobotics participating in the Truist Securities MedTech Conference, Boston Scientific's agreement to acquire Silk Road Medical for approximately $1.26 billion, and Salesforce.com launching an AI-powered Life Sciences Cloud to enhance engagements between pharma, MedTech companies, patients, and healthcare professionals.
    Daha fazlasını göster Daha Az Göster
    6 dk.